A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.

SK, Sinha; T, Lacaze-Masmonteil; i Soler A, Valls; TE, Wiswell; J, Gadzinowski; J, Hajdu; G, Bernstein; M, Sanchez-Luna; R, Segal; CJ, Schaber; J, Massaro; R, d'Agostino

doi:10.1542/peds.2004-2231

Public

A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.

Shared by NobleBlocks on Apr 1, 2005 • 12:00 AM UTC

Authors:

Sinha SK

Lacaze-Masmonteil T

Valls i Soler A

Abstract

<h4>Background</h4>Available therapeutic surfactants are either animal-derived or non-protein-containing synthetic products. Animal-derived surfactants contain variable amounts of surfactant apoproteins, whereas the older-generation synthetic products contain only phospholipids and lack surfactant p...

Discussions